Company / Net Income
Avidity Biosciences, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$684.6M
FY2025
5-year range
-$684.6M / -$118.0M
FY2021-FY2025
Trend
-112.4%
vs FY2024
Sector context
#203 of 216
Health Care
What the data says
Among 216 Health Care companies, Avidity Biosciences, Inc. is in the bottom 6% for net income. Net Income has declined for 7 consecutive years, from -$11M in FY2018 to -$685M in FY2025.
Based on SEC 10-K filings.
-$685M in FY2025.
Declined from -$212M to -$685M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 216This company -$684.6M Sector average $454.3M
▼
-250.7% below sector average
Key checks
Key Insights
- Avidity Biosciences, Inc.'s net income has declined for 7 consecutive years.
- In FY2025, net income decreased 112.4% year-over-year.
- Ranks #203 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$684.6M | -112.4% |
| FY2024 | -$322.3M | -51.9% |
| FY2023 | -$212.2M | -22.0% |
| FY2022 | -$174.0M | -47.4% |
| FY2021 | -$118.0M | -166.1% |
| FY2020 | -$44.4M | -79.3% |
| FY2019 | -$24.7M | -120.5% |
| FY2018 | -$11.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026